Generic drugs provide lifesaving, affordable treatment to millions of people each day. Generic drug manufacturing has been steadily moving from advanced economies, such as the U.S., to emerging economies, such as India. Due to the opacity of drug supply chains, the quality risk implications of manufacturing in emerging economies have not been carefully empirically tested. This study addresses this gap. To do so, we identify a novel source of drug manufacturing location data that allows us to compare the occurrence of serious adverse events of generic drugs made in different locations. Using exact matching analyses based on the equivalency criteria established by the U.S. Food and Drug Administration, we find that generic drugs manufactured in India, where a majority of emerging economy generic drugs are made, are associated with significantly higher instances of serious adverse events than equivalent generic drugs made in the U.S., where a majority of advanced economy generic drugs are made. We further show that this key result is explained by mature generic drugs, which are particularly susceptible to operations and supply chain cost reduction efforts—efforts that unfortunately may compromise drug quality. Our study finding leads to implications for the FDA in their regulation of generic drugs.
2 January 2026 in Production and Operations Management
Emerging technologies like artificial intelligence (AI) can influence the way people relate and coordinate to improve performance. Our research explores how human–AI interactions affect relational coordination and operational performance. Competing views suggest that AI may augment or substitute for human capabilities. To examine conflicting views, we build on affordance theory, which suggests that the interactions between people and technology provide (i.e., afford) multiple potential actions, which could stimulate or diminish human interactions. Given the importance of human interactions during times of increasing technology use, we focus on relational coordination with its explicit emphasis on human relationships built on mutual respect and shared goals in fostering coordination. We introduce and find evidence of the concepts of convergent and divergent affordances to explain how AI affordances can result in similar or different outcomes. We perform multiple progressive, behavioral experiments in a virtual factory setting where participants work in teams with three functional roles, including operations, demand, and quality. We randomly assign individuals to one of three treatment groups that differ in the number of teammates that receive recommendations from an analytical AI based on machine learning. Through quantitative, qualitative, replication, recording, and multiphase methods, we find that human–AI interactions can stimulate relational coordination between individuals and improve team performance. We propose a theoretical framework, the ACT cycle, that explains how people interact with AI and with one another based on discussion, trust, and use of AI. Through recording and observing teams, we find evidence of various paths of interaction in that framework. We also find that discussion of AI can stimulate relational coordination, particularly in early phases of team interactions. The results provide theoretical and practical insights into how AI can stimulate relational benefits of human–technology interactions.